Foghorn Therapeutics Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Foghorn Therapeutics Inc. (FHTX) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- Foghorn Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$1.00K.
- Foghorn Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$157.00K.
- Foghorn Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $0.00.
- Foghorn Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $68.00K, a 90.26% decline year-over-year.
- Foghorn Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$111.00K, a 111.55% decline from fiscal 2024.
- Foghorn Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $961.00K, a 69.59% decline from fiscal 2023.
- Foghorn Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $3.16M.
- Foghorn Therapeutics Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$3.98M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00K 10-Q · filed 2026-08-06 | -$158.00K 10-Q · filed 2026-08-06 | -$158.00K derived: sum of 3 quarters · filed 2026-08-06 | -$90.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$157.00K 10-Q · filed 2026-05-07 | -$157.00K derived: sum of 2 quarters · filed 2026-05-07 | -$89.00K derived: sum of 3 quarters · filed 2026-05-07 | -$147.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $68.00K derived: sum of 2 quarters · filed 2026-03-11 | $10.00K derived: sum of 3 quarters · filed 2026-08-06 | -$111.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | $68.00K 10-Q · filed 2025-11-05 | $10.00K derived: sum of 2 quarters · filed 2026-08-06 | -$111.00K 10-Q · filed 2025-11-05 | -$336.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$58.00K 10-Q · filed 2026-08-06 | -$179.00K 10-Q · filed 2026-08-06 | -$404.00K derived: sum of 3 quarters · filed 2026-08-06 | $294.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$121.00K 10-Q · filed 2026-05-07 | -$346.00K derived: sum of 2 quarters · filed 2026-05-07 | $352.00K derived: sum of 3 quarters · filed 2026-05-07 | $511.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $473.00K derived: sum of 2 quarters · filed 2026-03-11 | $632.00K derived: sum of 3 quarters · filed 2026-03-11 | $961.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | $698.00K 10-Q · filed 2025-11-05 | $857.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.19M 10-Q · filed 2025-11-05 | $2.25M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $159.00K 10-Q · filed 2025-08-05 | $488.00K 10-Q · filed 2025-08-05 | $1.55M derived: sum of 3 quarters · filed 2025-08-05 | $2.38M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $329.00K 10-Q · filed 2025-05-14 | $1.40M derived: sum of 2 quarters · filed 2025-05-14 | $2.22M derived: sum of 3 quarters · filed 2025-05-14 | $2.37M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.89M derived: sum of 2 quarters · filed 2025-03-06 | $2.04M derived: sum of 3 quarters · filed 2025-03-06 | $3.16M 10-K · filed 2025-03-06 |
| 2023-09-30 | $826.00K 10-Q · filed 2024-11-04 | $977.00K derived: sum of 2 quarters · filed 2024-11-04 | $2.09M 10-Q · filed 2024-11-04 | $2.97M derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | $151.00K 10-Q · filed 2024-08-08 | $1.27M 10-Q · filed 2024-08-08 | $2.15M derived: sum of 3 quarters · filed 2024-08-08 | $470.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.12M 10-Q · filed 2024-05-06 | $1.99M derived: sum of 2 quarters · filed 2024-05-06 | $319.00K derived: sum of 3 quarters · filed 2024-05-06 | -$1.68M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $878.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$797.00K derived: sum of 2 quarters · filed 2024-03-07 | -$2.79M derived: sum of 3 quarters · filed 2024-03-07 | -$3.98M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$1.68M 10-Q · filed 2023-11-02 | -$3.67M derived: sum of 2 quarters · filed 2023-11-02 | -$4.85M 10-Q · filed 2023-11-02 | -$4.85M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | -$2.00M 10-Q · filed 2023-08-04 | -$3.18M 10-Q · filed 2023-08-04 | -$3.18M derived: sum of 3 quarters · filed 2023-08-04 | -$3.18M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | -$1.18M 10-Q · filed 2023-05-08 | -$1.18M derived: sum of 2 quarters · filed 2023-05-08 | -$1.18M derived: sum of 3 quarters · filed 2023-05-08 | -$1.20M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $0.00 derived: sum of 2 quarters · filed 2023-03-09 | -$16.00K derived: sum of 3 quarters · filed 2023-03-09 | -$3.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | -$3.00K 10-Q · filed 2022-11-08 | -$19.00K derived: sum of 2 quarters · filed 2022-11-08 | -$6.00K 10-Q · filed 2022-11-08 | -$13.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$16.00K 10-Q · filed 2022-08-09 | -$3.00K 10-Q · filed 2022-08-09 | -$10.00K derived: sum of 3 quarters · filed 2022-08-09 | -$10.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $13.00K 10-Q · filed 2022-05-09 | $6.00K derived: sum of 2 quarters · filed 2022-08-09 | $6.00K derived: sum of 3 quarters · filed 2022-08-09 | $6.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2020-12-31 | -$7.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-08-09 | -$7.00K derived: sum of 2 quarters · filed 2022-08-09 | -$7.00K derived: sum of 3 quarters · filed 2022-08-09 | -$7.00K 10-K/A · filed 2022-08-09 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-10 | $0.00 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |